Updated Jul 16, 2026
Li Dean Y has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $2.99M.
Dean Y. Li is a director at Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on drug discovery. He has been involved in the company through various SEC filings, indicating his role in corporate governance.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 3.7K | $0.00 | |
| 2026-06-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 88.4K | $0.00 | |
| 2026-05-01 | MRK | Merck & Co., Inc. | F — Tax withholding / forfeiture | 2.3K | $110.03 | $256K |
| 2026-05-01 | MRK | Merck & Co., Inc. | M — Option exercise | 4.7K | $110.03 | $520K |
| 2026-04-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 3.3K | $0.00 | |
| 2026-02-10 | MRK | Merck & Co., Inc. | S — Open-market sale | 10.2K | $117.52 | $1.20M |
| 2026-02-06 | MRK | Merck & Co., Inc. | S — Open-market sale | 15.1K | $118.77 | $1.79M |
| 2026-02-06 | MRK | Merck & Co., Inc. | M — Option exercise | 15.1K | $56.04 | $845K |
| 2026-01-28 | MRK | Merck & Co., Inc. | A — Grant or award | 20.5K | $107.40 | $2.20M |
| 2025-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 2.0K | $0.00 | |
| 2025-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 1.9K | $0.00 | |
| 2024-10-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 1.9K | $0.00 |
Dean Y. Li is a director at Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on drug discovery. He has been involved in the company through various SEC filings, indicating his role in corporate governance.…
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($2.99M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Li Dean Y profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.